MMU banner 1

All posts by Dan Horner

Dr Daniel Horner BA MBBS MD PgCert MRCP (UK) FRCEM FFICM is an editorial board member on the St Emlyn’s blog and podcast. He is Professor of Emergency Medicine of the Royal College of Emergency Medicine. He is a consultant in Emergency Medicine and Intensive Care at Salford Royal NHS Foundation Trust. He is chair of the national exemplar centre Thrombosis Committee and Regional lead for Injuries and Emergencies on the NIHR Clinical Research Network. He is a Senior clinical lecturer at the University of Manchester and collaborator with the University of Sheffield. You can find him on twitter as @RCEMProf

VITT

Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s

I am sure you all saw the recent MHRA press release and guidance, discussing the issue of a possible link between the AstraZeneca COVID19 vaccine and a rare type of thrombotic condition of Vaccine induced

tocilizumab

Tocilizumabulous? A special offer on IL-6 with Tocilizumab.

It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it. Maybe not the one intervention

Tocilizumab

Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s

Hot on the heels of a terrific pun and blog post about the use of Tocilizumab, capturing all the intrigue, hope and caution with the potential use of this novel therapeutic agent for patients with severe

Tocilizumaybe? Immune modulation in COVID-19 @StEmlyns

I am sure many of you saw the breaking news on the BBC the other week, about a new wonderdrug to strengthen our defences against the tidal wave that is COVID19. This follows a press

TERN, the Delphi method and research priorities @St Emlyns

Research, trainees and prioritisation in UK emergency medicine.

The UK Trainee Emergency Research Network (TERN) was created (officially) in 2018 and mentioned previously by Simon & Dan in this early digital outing. The initial mission was to demystify clinical research, improve access to research

VTE and COVID-19: Would you like to know more?

That’s a leading question. Of course you would.  Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated

The ‘Roid’ to Recovery? REMAP-CAP @ St Emlyn’s

This week JAMA published three important trials on the use of steroids in patients with severe COVID-19, with an additional cherry on top; a subsequent inclusive meta-analysis (totalling 7 RCTs and 1703 patients) from the

Diagnosis and Treatment of VTE in the COVID-19 era

Ed – this post supports a webinar Dan gave with Thrombosis UK. We hope to link to that content when it’s ready. First of all, thanks to Thrombosis UK for inviting me to speak at

New NICE Guidelines on diagnosis and management of venous thromboembolism

In the midst of everything that is going on with COVID-19 it is easy to see how important non coronavirus stuff can get overlooked. But we still need to keep our eyes open. After a

Beyond the ED: COVID-19 and Critical Care

In this podcast, we talk about the clinical journey of a COVID-19 patient and some insights from the critical care unit. There are some concepts here that we probably don’t do full justice to in